Randomized trial demonstrates improved electrophysiological monitoring in human organoids, suggesting advancements in disease modeling and drug discovery.
Real-time, non-destructive monitoring of electrophysiological dynamics of 3D organoids is imperative for advancing disease modeling and high-throughput drug screening. However, obtaining continuous, reliable signals remains difficult due to the destructive nature of penetrating probes and the unreliable contact issue prone to surface recordings. Here, we present a stretchable 3D microelectrode array with microneedles (3D MN-sMEA) fabricated via a scalable wafer-level stud-bump bonding process for minimally destructive and stable monitoring. We achieve high-fidelity, reliable electrophysiological recordings of both human iPSC-derived heart and cerebral models. Compared with 2D and 3D planar microelectrodes, 3D microelectrodes with microneedles achieve a higher signal-to-noise ratio and greater long-term recording stability. Furthermore, quantitative pharmacological profiling validates its ability to enable precise drug screening. By combining scalable manufacturing with flexible, tissue-compliant interfaces, our approach enables stable, minimally invasive, and long-term electrophysiological monitoring of 3D organoids for scalable disease modeling and drug discovery.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: